Cargando…
Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration
BACKGROUND: Manganese-enhanced magnetic resonance imaging (MEMRI) for visual pathway imaging via topical administration requires further research. This study investigated the permeability of the corneal epithelium and corneal toxicity after topical administration of Mn(2+) to understand the applicab...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976571/ https://www.ncbi.nlm.nih.gov/pubmed/27453232 http://dx.doi.org/10.4103/0366-6999.186630 |
_version_ | 1782446895560392704 |
---|---|
author | Chen, Yao Shi, Chun-Yan Li, Ying Hu, Yun-Tao Han, Hong-Bin Sun, Xiao-Dong Salvi, Satyajeet S Ma, Zhi-Zhong |
author_facet | Chen, Yao Shi, Chun-Yan Li, Ying Hu, Yun-Tao Han, Hong-Bin Sun, Xiao-Dong Salvi, Satyajeet S Ma, Zhi-Zhong |
author_sort | Chen, Yao |
collection | PubMed |
description | BACKGROUND: Manganese-enhanced magnetic resonance imaging (MEMRI) for visual pathway imaging via topical administration requires further research. This study investigated the permeability of the corneal epithelium and corneal toxicity after topical administration of Mn(2+) to understand the applicability of MEMRI. METHODS: Forty New Zealand rabbits were divided into 0.05 mol/L, 0.10 mol/L, and 0.20 mol/L groups as well as a control group (n = 10 in each group). Each group was further subdivided into epithelium-removed and epithelium-intact subgroups (n = 5 in each subgroup). Rabbits were given 8 drops of MnCl(2) in 5 min intervals. The Mn(2+) concentrations in the aqueous and vitreous humors were analyzed using inductively coupled plasma-mass spectrometry at different time points. MEMRI scanning was carried out to image the visual pathway after 24 h. The corneal toxicity of Mn(2+) was evaluated with corneal imaging and pathology slices. RESULTS: Between the aqueous and vitreous humors, there was a 10 h lag for the peak Mn(2+) concentration times. The intraocular Mn(2+) concentration increased with the concentration gradients of Mn(2+) and was higher in the epithelium-removed subgroup than that in the epithelium-intact subgroup. The enhancement of the visual pathway was achieved in the 0.10 mol/L and 0.20 mol/L epithelium-removed subgroups. The corresponding peak concentrations of Mn(2+) were 5087 ± 666 ng/ml, 22920 ± 1188 ng/ml in the aqueous humor and 884 ± 78 ng/ml, 2556 ± 492 ng/ml in the vitreous body, respectively. Corneal injury was evident in the epithelium-removed and 0.20 mol/L epithelium-intact subgroups. CONCLUSIONS: The corneal epithelium is a barrier to Mn(2+), and the iris and lens septum might be another intraocular barrier to the permeation of Mn(2+). An elevated Mn(2+) concentration contributes to the increased permeation of Mn(2+), higher MEMRI signal, and corneal toxicity. The enhancement of the visual pathway requires an effective Mn(2+) concentration in the vitreous body. |
format | Online Article Text |
id | pubmed-4976571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-49765712016-08-25 Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration Chen, Yao Shi, Chun-Yan Li, Ying Hu, Yun-Tao Han, Hong-Bin Sun, Xiao-Dong Salvi, Satyajeet S Ma, Zhi-Zhong Chin Med J (Engl) Original Article BACKGROUND: Manganese-enhanced magnetic resonance imaging (MEMRI) for visual pathway imaging via topical administration requires further research. This study investigated the permeability of the corneal epithelium and corneal toxicity after topical administration of Mn(2+) to understand the applicability of MEMRI. METHODS: Forty New Zealand rabbits were divided into 0.05 mol/L, 0.10 mol/L, and 0.20 mol/L groups as well as a control group (n = 10 in each group). Each group was further subdivided into epithelium-removed and epithelium-intact subgroups (n = 5 in each subgroup). Rabbits were given 8 drops of MnCl(2) in 5 min intervals. The Mn(2+) concentrations in the aqueous and vitreous humors were analyzed using inductively coupled plasma-mass spectrometry at different time points. MEMRI scanning was carried out to image the visual pathway after 24 h. The corneal toxicity of Mn(2+) was evaluated with corneal imaging and pathology slices. RESULTS: Between the aqueous and vitreous humors, there was a 10 h lag for the peak Mn(2+) concentration times. The intraocular Mn(2+) concentration increased with the concentration gradients of Mn(2+) and was higher in the epithelium-removed subgroup than that in the epithelium-intact subgroup. The enhancement of the visual pathway was achieved in the 0.10 mol/L and 0.20 mol/L epithelium-removed subgroups. The corresponding peak concentrations of Mn(2+) were 5087 ± 666 ng/ml, 22920 ± 1188 ng/ml in the aqueous humor and 884 ± 78 ng/ml, 2556 ± 492 ng/ml in the vitreous body, respectively. Corneal injury was evident in the epithelium-removed and 0.20 mol/L epithelium-intact subgroups. CONCLUSIONS: The corneal epithelium is a barrier to Mn(2+), and the iris and lens septum might be another intraocular barrier to the permeation of Mn(2+). An elevated Mn(2+) concentration contributes to the increased permeation of Mn(2+), higher MEMRI signal, and corneal toxicity. The enhancement of the visual pathway requires an effective Mn(2+) concentration in the vitreous body. Medknow Publications & Media Pvt Ltd 2016-08-05 /pmc/articles/PMC4976571/ /pubmed/27453232 http://dx.doi.org/10.4103/0366-6999.186630 Text en Copyright: © 2016 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Chen, Yao Shi, Chun-Yan Li, Ying Hu, Yun-Tao Han, Hong-Bin Sun, Xiao-Dong Salvi, Satyajeet S Ma, Zhi-Zhong Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration |
title | Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration |
title_full | Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration |
title_fullStr | Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration |
title_full_unstemmed | Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration |
title_short | Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration |
title_sort | ability of mn(2+) to permeate the eye and availability of manganese-enhanced magnetic resonance imaging for visual pathway imaging via topical administration |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976571/ https://www.ncbi.nlm.nih.gov/pubmed/27453232 http://dx.doi.org/10.4103/0366-6999.186630 |
work_keys_str_mv | AT chenyao abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT shichunyan abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT liying abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT huyuntao abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT hanhongbin abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT sunxiaodong abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT salvisatyajeets abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration AT mazhizhong abilityofmn2topermeatetheeyeandavailabilityofmanganeseenhancedmagneticresonanceimagingforvisualpathwayimagingviatopicaladministration |